Brucella Seroprevalence in a High-Risk Population in Greece: A Cross-Sectional Study

Table 3

Comparative results of seroprevalence studies in endemic areas.

	RB	Wright STA	ELISA G	ELISA M	Parallel testing	Study
Mediterranean
Greece (100)	18%	8% (M)	8%	0%	3%^1
Turkey (573)	11.9%	5.4% (N/A)				Vancelik et al [27]
Spain (90)^2	0%	0% (A)	0%	0%		Gomez et al [28]
Turkey (528)	4%	5.2% (N/A)				Kose et al. [33]
Africa
Angola (132)					16.7%^3	Mufinda et al. [12]
Tanzania (67)	2%					Swai et. al. [25]
Uganda (140)	18.6%					Tumwine et al.[26]
Middle East
Iran (292)		5.5 % (N/A)				NIkokar et al [34]
Iran (250)^4		6.4% (N/A)				Esmaeli et al.[35]
Asia
Mongolia (2856)	11.1%					Tsend et al. [22]
India (121)^5	9.91%	9.09% (N/A)	16.52%			Sharma et al. [23]
Bangladesh (386)					2.86%^6	Rahman et al [24]

Results from seroprevalence studies in livestock farmers. In each study, the number of subjects is mentioned after the country. The study from Spain (Gomez et al.) is included because it provides the only other available seroprevalence data from Europe we identified in our literature search. In STA tests, M denotes melitensis, A denotes abortus, and N/A denotes being not mentioned.
¹RB and ELISA IgG.
²Healthy blood donors.
³Positive STA and ELISA.
All high-risk groups.
⁶Positive RB, STA, and ELISA.